BioLineRx (BLRX) Other Non-Current Assets (2011 - 2019)
BioLineRx's (BLRX) quarterly Other Non-Current Assets came in at $59000.0 in Q3 2019, down 10.61% year-on-year from $66000.0 in Q3 2018, and down 1.67% quarter-over-quarter from $60000.0 in Q2 2019.
BioLineRx (BLRX) Other Non-Current Assets (2011 - 2019) Analysis & Trends
BioLineRx's Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $59000.0 for Q3 2019.
- On a quarterly basis, Other Non-Current Assets fell 10.61% year-over-year to $59000.0 in Q3 2019; TTM through Sep 2019 was $59000.0, a 10.61% decrease from a year earlier, with the FY2018 full-year figure at $56000.0, down 8.2% from the prior year.
- Other Non-Current Assets retreated to $59000.0 in Q3 2019 per BLRX's latest filing, from $60000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.0 million in Q4 2016 and bottomed at $50000.0 in Q1 2015.
- The 5-year median for Other Non-Current Assets is $57000.0 (2015), against an average of $107000.0.
- Across the five-year window, Other Non-Current Assets soared 1624.14% in 2016 and sank 93.9% in 2017, its largest moves.
- Year by year, Other Non-Current Assets stood at $58000.0 in 2015, then surged by 1624.14% to $1.0 million in 2016, then plunged by 93.9% to $61000.0 in 2017, then dropped by 8.2% to $56000.0 in 2018, then advanced by 5.36% to $59000.0 in 2019.
- Per Business Quant, the three latest BLRX Other Non-Current Assets figures stand at $59000.0 (Q3 2019), $60000.0 (Q2 2019), and $55000.0 (Q1 2019).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | BioLineRx | 7.05 Bn | 7.06 Bn | 154,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 59,000.00 |
| Jun 30, 2019 | 60,000.00 |
| Mar 31, 2019 | 55,000.00 |
| Dec 31, 2018 | 56,000.00 |
| Sep 30, 2018 | 66,000.00 |
| Jun 30, 2018 | 63,000.00 |
| Mar 31, 2018 | 60,000.00 |
| Dec 31, 2017 | 61,000.00 |
| Sep 30, 2017 | 60,000.00 |
| Jun 30, 2017 | 53,000.00 |
| Mar 31, 2017 | 55,000.00 |
| Dec 31, 2016 | 1.00 Mn |
| Sep 30, 2016 | 54,000.00 |
| Jun 30, 2016 | 54,000.00 |
| Mar 31, 2016 | 56,000.00 |
| Dec 31, 2015 | 58,000.00 |
| Sep 30, 2015 | 56,000.00 |
| Jun 30, 2015 | 57,000.00 |
| Mar 31, 2015 | 50,000.00 |
| Dec 31, 2014 | 49,000.00 |